DHI

DR Horton
D

DHI

Arincen52/100B

DR Horton shares outstanding 1992–2026

DR Horton had 271,436,000 shares outstanding on 6 November 2026. DR Horton had 285.80M diluted shares on average over the last twelve months, down 7.8% on the twelve months before. In fiscal year 2026 the average was 285.80M.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026285.80M-7.78%284.80M
FY202630 Sept 2026285.80M-7.78%284.80M
FY202530 Sept 2025309.90M-6.54%308.50M
FY202430 Sept 2024331.60M-3.41%329.50M
FY202330 Sept 2023343.30M-3.24%340.70M
FY202230 Sept 2022354.80M-3.01%351.70M
FY202130 Sept 2021365.80M-1.19%361.10M
FY202030 Sept 2020370.20M-1.91%365.50M
FY201930 Sept 2019377.40M-1.56%372.60M
FY201830 Sept 2018383.40M+1.19%376.60M
FY201730 Sept 2017378.90M+1.01%374.30M
FY201630 Sept 2016375.10M+1.43%371.00M
FY201530 Sept 2015369.80M+0.87%366.30M
FY201430 Sept 2014366.60M+0.47%340.50M
FY201330 Sept 2013364.90M+1.64%322.10M
FY201230 Sept 2012359.00M+12.72%318.10M
FY201130 Sept 2011318.50M-0.03%318.30M
FY201030 Sept 2010318.60M+0.54%318.10M
FY200930 Sept 2009316.90M+0.38%316.90M
FY200830 Sept 2008315.70M+0.51%315.70M
FY200730 Sept 2007314.10M-0.67%314.10M
FY200630 Sept 2006316.23M-0.65%313.02M
FY200530 Sept 2005318.29M+0.74%312.21M
FY200430 Sept 2004315.95M-32.63%310.28M
FY200330 Sept 2003468.99M+66.30%464.56M
FY200230 Sept 2002282.01M+22.17%268.89M
FY200130 Sept 2001230.84M+1.61%226.77M
FY200030 Sept 2000227.19M-10.30%225.59M
FY199930 Sept 1999253.28M+24.97%247.87M
FY199830 Sept 1998202.67M+49.62%202.67M
FY199730 Sept 1997135.45M+18.77%135.45M
FY199630 Sept 1996114.04M+5.98%114.04M
FY199530 Sept 1995107.61M+8.74%107.61M
FY199430 Sept 199498.96M-1.82%98.96M
FY199330 Sept 1993100.79M+4.16%100.79M
FY199230 Sept 199296.77M—96.77M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about DR Horton's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.